Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Catalyst Pharmaceuticals Inc    CPRX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/01/2016 02/02/2016 02/03/2016 02/04/2016 02/05/2016 Date
1.92(c) 1.85(c) 1.82(c) 1.9(c) 1.79(c) Last
334 791 586 061 437 001 457 544 363 301 Volume
+3.23% -3.65% -1.62% +4.40% -5.79% Change
More quotes
Financials ($)
Sales 2015 -
EBIT 2015 -20,6 M
Net income 2015 -20,6 M
Debt 2015 -
Yield 2015 -
Sales 2016 17,5 M
EBIT 2016 -11,8 M
Net income 2016 -11,9 M
Debt 2016 -
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
Capi. / Sales 2015 0
Capi. / Sales 2016 8,41x
Capitalization 147 M
More Financials
Company
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.The company has three drug candidates in development: Firdapse, CPP-115 and CPP-109.The company was founded by McEnany J. Patrick... 
More about the company
Surperformance© ratings of Catalyst Pharmaceuticals I
Trading Rating : Investor Rating : -
More Ratings
Latest news on CATALYST PHARMACEUTICALS I
02/04 Catalyst Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Con..
2015 CATALYST PHARMACEUTICALS : Announces Top-Line Results in Phase 1(b) Trial of CPP..
2015 Catalyst Pharmaceuticals Completes NDA Submission to FDA for Firdapse for the..
2015 CATALYST PHARMACEUTICALS : Announces Top-Line Results in Phase 1(b) Trial of CPP..
2015 Catalyst Pharmaceuticals Announces Top-Line Results in Phase 1(b) Trial of C..
2015 CATALYST PHARMACEUTICALS : to Present at the 27th Annual Piper Jaffray Healthcar..
2015 Catalyst Pharmaceuticals to Present at the 27th Annual Piper Jaffray Healthca..
2015 CATALYST PHARMACEUTICALS : reports 3Q loss
More news
Sector news : Bio Therapeutic Drugs
02/05 AMGEN : To Present At The Leerink Partners 5th Annual Global Healthcare Conferen..
02/05 AMGEN : Positive topline results from GAUSS-3 trial of Repatha
02/05 SANOFI : Muzammil Mansuri is Sanofi’s new Executive Committee member
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
01/08 INSIDERINSIGHTS.COM DAILY ROUND UP 1 : Spark Networks, Opko Health, Aircastle, S..
2015 PREMARKET BIOTECH DIGEST : Shkreli Arrested, Exelixis' Catalyst, Gilead-Galapago..
2015 Catalyst Pharma finishes rolling Firdapse NDA submission for ultra-rare disea..
2015 Catalyst Pharmaceutical Partners' (CPRX) CEO Pat McEnany on Q3 2015 Results -..
2015 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am


Comments 
Advertisement
Chart CATALYST PHARMACEUTICALS I
Duration : Period :
Catalyst Pharmaceuticals I Technical Analysis Chart | CPRX | US14888U1016 | 4-Traders
Full-screen chart
Technical analysis trends CATALYST PHARMACE...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions